A synbiotic formula developed by researchers at the Chinese University of Hong Kong (CUHK) is shown to hasten recovery and increase the production of neutralizing antibodies in hospitalized patients with coronavirus disease 2019 (COVID-19).
Exenatide once weekly provides effective glucose control and weight loss in patients with type 2 diabetes mellitus, and these benefits are sustained through 18 months of treatment, according to real-world data.
Women who are overweight or obese do not necessarily have lower chances of a successful birth following infertility treatments, including intrauterine insemination, relative to women with normal weight, a study has found.
Use of antipsychotics results in an elevated risk of acute respiratory failure (ARF) in adult patients, results of a recent study have shown. This risk is dose-dependent and significantly greater with current use of antipsychotics agents at doses of 1 defined daily dose and above.
Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).